You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?
Sampo Q2'24: Topdanmark in Focus
Sampo continued its steady performance. The most significant recent news is the acquisition of Topdanmark. Sampo's CFO Knut Arne Alsaker commented on Topdanmark, the profitability of Hastings, and the profitability of health insurance in an interview on inderesTV.
00:00 Q2 development
01:05 Premium growth
02:20 Investment returns
04:05 Personal insurance profitability
08:00 Hastings profitability
10:37 Topdanmark
13:25 Synergies
Herantis Pharma as an Investment | Life Science Night Dec. 2, 2024
Aiforia as an Investment | Life Science Night Dec. 2, 2024
Faron Pharmaceuticals as an Investment | Life Science Night Dec. 2, 2024
Life Science Companies as Investments | Life Science Night Dec. 2, 2024
Life Science Night | December 2, 2024
Titta på alla videor